Enrollment in Clinical Trials Correlates with Improved Survival in Metastatic Melanoma

Publisher： Karger

E-ISSN： 1423-0232|81|5-6|403-409

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.5-6, 2012-01, pp. : 403-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials

By  

Oncology, Vol. 81, Iss. 2, 2011-10 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Physicians declining patient enrollment in clinical trials: what are the implications?

By De Backer Daniel   Schortgen Frédérique  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 117-119

Springer Publishing Company

Access to resources Recommend Favorite

Clinical activity of ipilimumab for metastatic uveal melanoma

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3687-3695

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib

By  

Oncology Research and Treatment, Vol. 40, Iss. 4, 2017-03 ,pp. : 174-183

Karger

Access to resources Recommend Favorite

Clinical Trials and Survival Curves: The Shape of Things to Come

By  

Acta Haematologica, Vol. 105, Iss. 3, 2001-07 ,pp. : 188-194

Karger

Access to resources Recommend Favorite